Literature DB >> 2523462

Effects of the supernatants of mixed lymphocyte cultures and decidual cell line cultures on mouse embryo development in vitro.

A Fukuda1, T Mori, E Mori, K Tatsumi, H Kanzaki, T Mori.   

Abstract

The effects of supernatants of human mixed lymphocyte cultures (MLC), with or without human decidual cell line culture extract (decidual factor; DCF), on F1-hybrid mouse embryo development in vitro from the two-cell stage were investigated. The development of mouse embryos from the two-cell stage through the expanded blastocyst stage was facilitated significantly by the addition of supernatants of not only MLC, but also MLC supplemented with DCF (MLCDCF) to the culture medium. Moreover, the supernatant of MLCDCF accelerated the attachment of the hatched blastocyst to the culture dish substratum and the outgrowth of trophoblasts in vitro. The findings indicate that the supernatant of MLCDCF facilitates the in vitro activity of mouse embryos for implantation and that the maternal immune response, along with the decidual tissue, contributes to the implantation processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523462     DOI: 10.1007/bf01134583

Source DB:  PubMed          Journal:  J In Vitro Fert Embryo Transf        ISSN: 0740-7769


  17 in total

1.  Uterus of rodents as site for manifestation of transplantation immunity against transplantable tumors.

Authors:  M SCHLESINGER
Journal:  J Natl Cancer Inst       Date:  1962-04       Impact factor: 13.506

Review 2.  Some genetic aspects of fertilization, implantation and development.

Authors:  B Clarke; D R Kirby
Journal:  J Obstet Gynaecol Br Commonw       Date:  1967-12

3.  Prevention of recurrent abortion with leucocyte transfusions.

Authors:  C Taylor; W P Faulk
Journal:  Lancet       Date:  1981-07-11       Impact factor: 79.321

4.  HLA-DR compatibility in couples with recurrent spontaneous abortions.

Authors:  K Aoki
Journal:  Nihon Sanka Fujinka Gakkai Zasshi       Date:  1982-10

5.  Maintenance of histocompatibility polymorphisms.

Authors:  B Clarke; D R Kirby
Journal:  Nature       Date:  1966-08-27       Impact factor: 49.962

6.  Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro.

Authors:  J A Hill; F Haimovici; D J Anderson
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

7.  Immunoregulatory activity of supernatants from short-term cultures of mouse decidual tissue.

Authors:  M T Badet; S C Bell; W D Billington
Journal:  J Reprod Fertil       Date:  1983-07

8.  The immunostimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells.

Authors:  I Athanassakis; R C Bleackley; V Paetkau; L Guilbert; P J Barr; T G Wegmann
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

9.  Immunoregulatory factor released from a cell line derived from human decidual tissue.

Authors:  K Tatsumi; T Mori; E Mori; H Kanzaki; T Mori
Journal:  Am J Reprod Immunol Microbiol       Date:  1987-03

10.  Differential immunofluorescence of fertilized mouse eggs with H-2 and non-H-2 antibody.

Authors:  J Palm; S Heyner; R L Brinster
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  3 in total

1.  Modulation of mouse sperm-egg interaction, early embryonic development and trophoblastic outgrowth by activated and unactivated macrophages.

Authors:  S C Juneja; T L Pfeifer; X M Tang; R S Williams; N Chegini
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

Review 2.  In vitro fertilization (IVF) in mammals: epigenetic and developmental alterations. Scientific and bioethical implications for IVF in humans.

Authors:  Patricio Ventura-Juncá; Isabel Irarrázaval; Augusto J Rolle; Juan I Gutiérrez; Ricardo D Moreno; Manuel J Santos
Journal:  Biol Res       Date:  2015-12-18       Impact factor: 5.612

3.  Human T cell leukemia cell death by apoptosis-inducing nucleosides from CD57(+) HLA-DR(bright) natural suppressor cell line.

Authors:  T Mori; X Li; E Mori; M Guo
Journal:  Jpn J Cancer Res       Date:  2000-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.